SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (16924)6/14/2004 12:42:25 AM
From: Bluegreen  Respond to of 17367
 
Read toward the end about Raptiva.>>>>>>http://www.ubs.wallst.com/ubs/mkt_story.asp?docKey=354-L01288280-3U6U2LKQOK8RAQI1626HTNLDER&first=0



To: Robert K. who wrote (16924)6/16/2004 12:39:34 AM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
Is this the last part of the puzzle?>>>>>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15183063



To: Robert K. who wrote (16924)6/20/2004 11:57:15 PM
From: Bluegreen  Respond to of 17367
 
Not just mousing around! Look what happens when the mabs are given.>>>>>>>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12834612



To: Robert K. who wrote (16924)6/23/2004 12:45:39 AM
From: Bluegreen  Respond to of 17367
 
Look at this first paragraph. Then look at the reference publications infra. Notice that NYU moniker!!! >>>>>>>http://www.med.nyu.edu/honors/hioe.htm



To: Robert K. who wrote (16924)6/23/2004 1:38:25 AM
From: Bluegreen  Respond to of 17367
 
Bob, if Genentech was doing secret HIV trials involving Raptiva would Dr. Hildreth be involved? Why is Cytodyn planning to start a Phase II trial of Cytolin this August or September?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News